Fredun Pharmaceuticals Ltd
BSE:539730
Cash Flow Statement
Cash Flow Statement
Fredun Pharmaceuticals Ltd
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
23
|
21
|
20
|
37
|
63
|
80
|
108
|
129
|
156
|
177
|
200
|
278
|
|
| Depreciation & Amortization |
19
|
19
|
20
|
16
|
22
|
24
|
28
|
39
|
38
|
41
|
50
|
0
|
|
| Change in Deffered Taxes |
1
|
(5)
|
4
|
7
|
1
|
(3)
|
24
|
58
|
3
|
(39)
|
0
|
0
|
|
| Other Non-Cash Items |
40
|
35
|
21
|
56
|
32
|
87
|
39
|
0
|
185
|
278
|
297
|
238
|
|
| Cash Interest Paid |
44
|
39
|
42
|
35
|
47
|
55
|
93
|
129
|
137
|
174
|
224
|
274
|
|
| Change in Working Capital |
(190)
|
152
|
(63)
|
(381)
|
(141)
|
(404)
|
(343)
|
315
|
(387)
|
(1 405)
|
(838)
|
(192)
|
|
| Cash from Operating Activities |
(106)
N/A
|
222
N/A
|
2
-99%
|
(266)
N/A
|
(24)
+91%
|
(235)
-889%
|
(144)
+39%
|
580
N/A
|
(4)
N/A
|
(949)
-21 529%
|
(291)
+69%
|
360
N/A
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(15)
|
(4)
|
(14)
|
0
|
(43)
|
(105)
|
(95)
|
(119)
|
(76)
|
(70)
|
(61)
|
(188)
|
|
| Other Items |
0
|
0
|
0
|
5
|
1
|
0
|
1
|
0
|
0
|
0
|
(2)
|
0
|
|
| Cash from Investing Activities |
(15)
N/A
|
(4)
+74%
|
(14)
-263%
|
2
N/A
|
(41)
N/A
|
(109)
-164%
|
(94)
+14%
|
(119)
-26%
|
(76)
+36%
|
(70)
+8%
|
(64)
+9%
|
(190)
-200%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
5
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
182
|
(151)
|
47
|
252
|
131
|
445
|
341
|
(300)
|
190
|
1 136
|
616
|
233
|
|
| Other |
(44)
|
(39)
|
(55)
|
(48)
|
(57)
|
(65)
|
(89)
|
(125)
|
(130)
|
(167)
|
(226)
|
(276)
|
|
| Cash from Financing Activities |
137
N/A
|
(190)
N/A
|
(7)
+96%
|
204
N/A
|
75
-63%
|
385
+415%
|
252
-35%
|
(428)
N/A
|
60
N/A
|
967
+1 513%
|
391
-60%
|
(43)
N/A
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
16
N/A
|
28
+73%
|
(19)
N/A
|
(59)
-208%
|
10
N/A
|
40
+320%
|
14
-66%
|
34
+147%
|
(21)
N/A
|
(52)
-151%
|
37
N/A
|
127
+243%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(121)
N/A
|
218
N/A
|
(12)
N/A
|
(266)
-2 080%
|
(67)
+75%
|
(341)
-412%
|
(239)
+30%
|
461
N/A
|
(81)
N/A
|
(1 019)
-1 162%
|
(352)
+65%
|
172
N/A
|
|